Chimerix's Brincidofovir Selected For Use In Ebola Clinical Trial In West Africa By International Consortium
November 13, 2014 at 12:34 PM EST
Chimerix, Inc. (Nasdaq: CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, ...